TGX-221 is a p110-specific inhibitor with IC50 of 5 nM, 1000-fold more selective for p110 than p110.
For research use only. We do not sell to patients.
| Name | TGX-221 |
|---|---|
| Iupac Chemical Name | 7-methyl-2-morpholino-9-(1-(phenylamino)ethyl)-4H-pyrido[1,2-a]pyrimidin-4-one |
| Synonyms | TGX-221; TGX221; TGX 221 |
| Molecular Formula | C21H24N4O2 |
| Molecular Weight | 364.44 |
| Smile | CC=1C=C(C=2N(C(C=C(N2)N2CCOCC2)=O)C1)C(C)NC1=CC=CC=C1 |
| InChiKey | CPRAGQJXBLMUEL-UHFFFAOYSA-N |
| InChi | InChI=1S/C21H24N4O2/c1-15-12-18(16(2)22-17-6-4-3-5-7-17)21-23-19(13-20(26)25(21)14-15)24-8-10-27-11-9-24/h3-7,12-14,16,22H,8-11H2,1-2H3 |
| CAS Number | 663619-89-4 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | light yellow solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | 5mg/ml in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |